XML 24 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Revenues:      
Premiums $ 308,810 $ 290,827 $ 257,157
Investment and other income 5,202 4,089 2,030
Total revenues 400,278 371,622 324,162
Operating costs:      
Medical costs 264,185 241,894 210,842
Operating costs 53,013 54,628 47,782
Cost of products sold 46,694 38,770 33,703
Depreciation and amortization 4,099 3,972 3,400
Total operating costs 367,991 339,264 295,727
Earnings from operations 32,287 32,358 28,435
Interest expense (3,906) (3,246) (2,092)
Loss on sale of subsidiary and subsidiaries held for sale (8,310) 0 0
Earnings before income taxes 20,071 29,112 26,343
Provision for income taxes (4,829) (5,968) (5,704)
Net earnings 15,242 23,144 20,639
Earnings attributable to noncontrolling interests (837) (763) (519)
Net earnings attributable to UnitedHealth Group common shareholders $ 14,405 $ 22,381 $ 20,120
Earnings per share attributable to UnitedHealth Group common shareholders:      
Basic $ 15.64 $ 24.12 $ 21.47
Diluted $ 15.51 $ 23.86 $ 21.18
Basic weighted-average number of common shares outstanding 921 928 937
Dilutive effect of common share equivalents 8 10 13
Diluted weighted-average number of common shares outstanding 929 938 950
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents 6 6 3
Products      
Revenues:      
Revenue from Products and Services $ 50,226 $ 42,583 $ 37,424
Services      
Revenues:      
Revenue from Products and Services $ 36,040 $ 34,123 $ 27,551